Christophe Caux

This inventor holds 14 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 4 EPO patents, primarily in Immunotherapy Research. Top assignees: Centre Leon Berard, Institut Jean Paoli & Irène Calmettes, National Institute of Health and Medical Research. Active years: 1999-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christophe Caux. Retrieved from https://idiyas.com/inventor/christophe-caux

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 5)

% Patents Active = 85.7

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 69(Granted Patents)

Location History:

Lyon, FR (2001)
Lyons, FR (1999 - 2021)
Bressolles, FR (2003 - 2021)

Company Filing History:

Institut Jean Paoli & Irène Calmettes

patents

6 out of 1,853

National Institute of Health and Medical Research

Université´ D'aix-Marseille

patents

6. 4 out of 215

University Claude Bernard - Lyon 1

Schering-Plough Corporation

patents

9. 1 out of 10

Université Claude Bernard

patents

10. 1 out of 1

Universite Claude Bernerd—lyon }

patent

where one patent can have more than one assignee

Years Active: 1999-2021

Loading Chart...

Areas of Expertise:

Antibodies

ICOS

CD73

Chimeric Receptors

Chemokines

Dendritic Cells

Inflammatory Conditions

Mammalian Proteinases

Screening Assay

Agonists

Antagonists

Immune Response

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11180556 - Antibodies directed against ICOS and uses thereof (2021-11-23),

2. 11130817 - CD73 blocking agents (2021-09-28),

3. 10745482 - Antibodies directed against ICOS and uses thereof (2020-08-18),

4. 10633446 - Antibodies directed against ICOS and uses thereof (2020-04-28),

5. 9975950 - Antibodies directed against ICOS and uses thereof (2018-05-22),

6. 9676852 - Antibodies directed against ICOS and uses thereof (2017-06-13),

7. 9376493 - Antibodies directed against ICOS and uses thereof (2016-06-28),

8. 7700728 - Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptors (2010-04-20),

9. 7217700 - Chemokines as adjuvants of immune response (2007-05-15),

10. 6812004 - Mammalian dendritic cell chemokine reagents (2004-11-02),

11. 6645491 - Method for treating inflammatory conditions using an antibody to MIP-3&agr; (2003-11-11),

12. 6361939 - Isolated mammalian dendritic cell genes; related reagents (2002-03-26),

13. 6271014 - Mammalian proteinases; related reagents and methods (2001-08-07),

14. 6004807 - In vitro generation of human dendritic cells (1999-12-21),

Title: Christophe Caux: Pioneering Inventor from Lyons, FR

Introduction: Christophe Caux is a distinguished inventor hailing from Lyons, France, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Christophe Caux holds several patents in the areas of renewable energy, sustainable transportation, and advanced materials, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Christophe Caux has worked with leading research institutions and companies to develop cutting-edge technologies that have revolutionized various industries.

Collaborations: Throughout his career, Christophe Caux has collaborated with top engineers, scientists, and inventors from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Christophe Caux's passion for innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.